Viewing StudyNCT00372710



Ignite Creation Date: 2024-05-05 @ 5:02 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00372710
Status: TERMINATED
Last Update Posted: 2009-11-23
First Post: 2006-09-06

Brief Title: SafetyEfficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Breast Cancer With Bone Metastasis
Keywords:
Name View
Zoledronic acid View
Breast cancer View
Palliation View
Bone metastasis View